Skip to main content
Premium Trial:

Request an Annual Quote

U of Liverpool Center Joins Roche NimbleGen CSP Program

NEW YORK (GenomeWeb News) – Roche today announced that the Centre for Genomic Research at the University of Liverpool in the UK has joined the Roche NimbleGen Certified Service Provider program.

As a result, CGR is certified to perform next-generation sequencing target enrichment services with customer samples using the NimbleGen SeqCap EZ workflow. Roche said that CGR is the first facility authorized in the UK to provide SeqCap EZ target enrichment services.

Roche discontinued its NimbleGen microarray business in 2012 but continued to develop and sell sequence capture products. In April, the company also said that it was shutting down its Applied Science Business Area. BioArray News reported at the time, though, that the sequence capture business would not be affected by the change.

The Scan

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.

Study Reveals Potential Sex-Specific Role for Noncoding RNA in Depression

A long, noncoding RNA called FEDORA appears to be a sex-specific regulator of major depressive disorder, affecting more women, researchers report in Science Advances.

New mRNA Vaccines Offer Hope for Fighting Malaria

A George Washington University-led team has developed mRNA vaccines for malaria that appear to provide protection in mice, as they report in NPJ Vaccines.

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.